JPH0365350B2 - - Google Patents

Info

Publication number
JPH0365350B2
JPH0365350B2 JP59061285A JP6128584A JPH0365350B2 JP H0365350 B2 JPH0365350 B2 JP H0365350B2 JP 59061285 A JP59061285 A JP 59061285A JP 6128584 A JP6128584 A JP 6128584A JP H0365350 B2 JPH0365350 B2 JP H0365350B2
Authority
JP
Japan
Prior art keywords
methyl
methoxyiminoacetamide
carboxylate
aminothiazole
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP59061285A
Other languages
English (en)
Japanese (ja)
Other versions
JPS59219292A (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS59219292A publication Critical patent/JPS59219292A/ja
Publication of JPH0365350B2 publication Critical patent/JPH0365350B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/587—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP59061285A 1983-03-30 1984-03-30 有機化合物 Granted JPS59219292A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US480602 1983-03-30
US06/480,602 US4525473A (en) 1983-03-30 1983-03-30 Cephalosporins

Publications (2)

Publication Number Publication Date
JPS59219292A JPS59219292A (ja) 1984-12-10
JPH0365350B2 true JPH0365350B2 (en, 2012) 1991-10-11

Family

ID=23908592

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59061285A Granted JPS59219292A (ja) 1983-03-30 1984-03-30 有機化合物

Country Status (5)

Country Link
US (1) US4525473A (en, 2012)
EP (1) EP0121244B1 (en, 2012)
JP (1) JPS59219292A (en, 2012)
AT (1) ATE56454T1 (en, 2012)
DE (1) DE3483165D1 (en, 2012)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3409431A1 (de) * 1983-10-08 1985-04-18 Hoechst Ag, 6230 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
GB8401093D0 (en) * 1984-01-16 1984-02-15 Fujisawa Pharmaceutical Co Cephem compounds
NZ211223A (en) * 1984-03-05 1988-02-12 Teijin Ltd Cephalosporins and pharmaceutical compositions
JPS60231683A (ja) * 1984-05-02 1985-11-18 Teijin Ltd セフアロスポリン誘導体その製造法及びそれを有効成分とする抗菌剤
US4880795A (en) * 1984-05-22 1989-11-14 Bayer Aktiengesellschaft Cephalosporins
DE3419013A1 (de) * 1984-05-22 1985-11-28 Bayer Ag, 5090 Leverkusen Neue cephalosporine und verfahren zu ihrer herstellung
DE3419012A1 (de) * 1984-05-22 1985-11-28 Bayer Ag, 5090 Leverkusen Ss-lactamantibiotika, verfahren zu deren herstellung sowie ihre verwendung als arzneimittel oder wachstumsfoerderer in der tieraufzucht oder als antioxidantien
GB8424692D0 (en) * 1984-10-01 1984-11-07 Glaxo Group Ltd Chemical compounds
GB2165245B (en) * 1984-10-01 1988-05-25 Glaxo Group Ltd Chemical compounds
US4680409A (en) * 1984-10-09 1987-07-14 E. R. Squibb & Sons, Inc. Hydrazide containing derivatives of 2-amino-4-thiazole-acetic acid
DE3581891D1 (de) * 1984-11-12 1991-04-04 Banyu Pharma Co Ltd Cephalosporinderivate.
US4883868A (en) * 1984-12-27 1989-11-28 Banyu Pharmaceutical Co., Ltd. 7-amino-3-(substituted isoindolinium)methyl-3-cephem derivatives
DE3587997D1 (de) * 1984-12-27 1995-04-06 Banyu Pharma Co Ltd Isoindolinderivate.
JPH0645629B2 (ja) * 1985-08-06 1994-06-15 萬有製薬株式会社 新規セフアロスポリン誘導体
IL77458A (en) * 1985-01-14 1990-07-26 Eisai Co Ltd Cephem derivatives,their production and antibacterial compositions containing them and certain novel intermediates therefor
US4698336A (en) * 1985-01-30 1987-10-06 Eisai Co., Ltd. 3-(pyrrolidinio)methyl-3-cephem derivatives
JPS6290A (ja) * 1985-01-30 1987-01-06 Eisai Co Ltd ３−（ピロリジニオ）メチル−３−セフエム誘導体
DE3506159A1 (de) * 1985-02-22 1986-08-28 Bayer Ag, 5090 Leverkusen Neue cephalosporine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
CA1284994C (en) * 1985-08-05 1991-06-18 Murray Arthur Kaplan Cephalosporin salts and injectable compositions
US4910301A (en) * 1985-08-05 1990-03-20 Bristol-Myers Company Cefepime cephalosporin salts
DE3789466T2 (de) * 1986-03-17 1994-07-28 Fujisawa Pharmaceutical Co 3,7-Disubstituierte-3-Cephemverbindungen und Verfahren zu ihrer Herstellung.
US4814328A (en) * 1986-03-19 1989-03-21 Banyu Pharmaceutical Co., Ltd. Cephalosporin derivatives, and antibacterial agents
SE8602339D0 (sv) * 1986-05-22 1986-05-22 Astra Laekemedel Ab An efficient stereoconservative synthesis of 1-substituted (s)- and (r)-2-aminomethylpyrrolidines
US5147871A (en) * 1986-07-03 1992-09-15 Hoffmann La-Roche, Inc. Anti-bacterial cephalosporin compounds
JP2690009B2 (ja) * 1986-07-10 1997-12-10 エーザイ 株式会社 セフアロスポリン注射剤
IL84128A (en) * 1986-10-13 1992-12-01 Eisai Co Ltd 3-propenylcephem derivatives, their preparation and pharmaceutical compositions containing them
US5336768A (en) * 1988-05-24 1994-08-09 Hoffmann-La Roche Inc. Antibacterial cephalosporin compounds
YU63689A (en) * 1988-03-31 1991-06-30 Hoffmann La Roche Acyl derivatives
US5244890A (en) * 1988-06-06 1993-09-14 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
US5159077A (en) * 1989-07-21 1992-10-27 Hoffmann-La Roche Inc. Penam antibacterial compounds
US5162523A (en) * 1989-07-21 1992-11-10 Hoffmann-La Roche Inc. Cephalosporin antibacterial compounds
US5143910A (en) * 1989-09-07 1992-09-01 Shionogi & Co., Ltd. Piperaziniocephalosporins
JPH0867676A (ja) * 1994-03-30 1996-03-12 Eisai Kagaku Kk 保護アミノチアゾリル酢酸誘導体
TW526202B (en) 1998-11-27 2003-04-01 Shionogi & Amp Co Broad spectrum cephem having benzo[4,5-b]pyridium methyl group of antibiotic activity
TW200305422A (en) * 2002-03-18 2003-11-01 Shionogi & Co Broad spectrum cefem compounds
CN102040615B (zh) * 2009-10-12 2012-12-26 山东轩竹医药科技有限公司 含有二氢吡咯并环烷基的头孢抗生素

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE280565C (en, 2012) *
GB1399086A (en) * 1971-05-14 1975-06-25 Glaxo Lab Ltd Cephalosporin compounds
DE2760484C2 (en, 2012) * 1976-04-14 1992-12-03 Takeda Chemical Industries, Ltd., Osaka, Jp
GB1591439A (en) * 1976-10-01 1981-06-24 Glaxo Operations Ltd 7-syn (oxyimino -acylamido) cephalosporins
JPS53103493A (en) * 1977-02-18 1978-09-08 Takeda Chem Ind Ltd Cephalosporin derivatives and process for their preparation
DE2714880A1 (de) * 1977-04-02 1978-10-26 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung
PL238158A1 (en) * 1981-09-08 1984-11-19 Lilly Co Eli Method of obtaining new cephalosporin derivatives
US4406899A (en) * 1982-03-04 1983-09-27 Bristol-Myers Company Cephalosporins
US4457929A (en) * 1982-03-29 1984-07-03 Bristol-Myers Company 3-Quaternary ammonium methyl)-substituted cephalosporin derivatives
ATE30724T1 (de) * 1982-06-28 1987-11-15 Bristol Myers Co Cephalosporinderivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die sie enthalten.

Also Published As

Publication number Publication date
EP0121244B1 (en) 1990-09-12
EP0121244A3 (en) 1985-10-02
EP0121244A2 (en) 1984-10-10
ATE56454T1 (de) 1990-09-15
DE3483165D1 (de) 1990-10-18
US4525473A (en) 1985-06-25
JPS59219292A (ja) 1984-12-10

Similar Documents

Publication Publication Date Title
JPH0365350B2 (en, 2012)
US4406899A (en) Cephalosporins
KR880001541B1 (ko) 세팔로스포린 유도체의 제조방법
US4457929A (en) 3-Quaternary ammonium methyl)-substituted cephalosporin derivatives
US4500526A (en) Cephalosporin derivatives
US6057312A (en) Cephalosporin antibiotics
RU2056425C1 (ru) Производные цефалоспорина или их фармацевтически приемлемые кислотно-аддитивные соли и способы их получения
JPS625916B2 (en, 2012)
CA1225390A (en) 3-bicyclicpyridinium-methyl cephalosporins
KR870001986B1 (ko) 세팔로스포린 유도체의 제조방법
US5202315A (en) Cephalosporin compounds
FI74971C (fi) Foerfarande foer framstaellning av en terapeutiskt aktiv syn-isomer av en 7-(2-aminotiazolyl-2-hydroxi -iminoacetamido)-3-vinyl-3-cefemfoerening.
US4748172A (en) 3-bicyclicpyridinium-methyl cephalosporins
US4708955A (en) 3-(substituted)propenyl-7-aminothiazol-ylcephalosporanic acids and esters thereof
EP0097961B1 (en) Cephalosporin derivatives, a process for the manufacture thereof and pharmaceutical compositions containing said derivatives
US4874856A (en) 3-(substituted)propenyl-7-(aminothiazolylacetamido) ceph-3-em-4-carboxylic acids and esters thereof
US4665066A (en) 3-thiazolomethyl cephalosporins as antibiotics
KR830001891B1 (ko) 세팔로스포린 항생물질의 제조방법
EP0181172A2 (en) Cephalosporin antibiotics
US4560683A (en) Cephalosporin antibiotics
KR100377559B1 (ko) 경구투여 가능한 세팔로스포린계 화합물 및 이의 제조방법
CA2053456C (en) Novel cephem compounds, their preparation processes and antibacterial agents
US5416081A (en) Cephalosporin compounds
JP2002514650A (ja) 新規なセファロスポリン化合物、その製造方法およびそれを含有する抗菌性組成物
KR910007980B1 (ko) 신규 세팔로스포린계 항생제 및 이의 제조방법